Leveraging Pioneering Circadian Rhythm Biology.

Developing Transformative Therapies.

Founded by pioneers in circadian biology research, Synchronicity Pharma is focused on exploiting the burgeoning understanding of body clock and its role in treating a variety of diseases. Synchronicity is committed to improving patients’ lives by targeting components of the clock machinery.

Synchronicity developed the first ever clinical stage compound shown to safely target the core-clock molecular machinery and to modulate clock-regulated gene expression in humans.

The company’s Cryptochrome modulator programs enable, for the first time, transformative clock-based therapies across a broad range of diseases areas.